Skip to main content
. 2018 Nov 7;13(6):757–767. doi: 10.1007/s11523-018-0602-1
Scoring methods for stromal tumor-infiltrating lymphocytes (sTILs) as recommended by the International TILs Working Group were feasible in clinical practice.
Higher baseline sTILs in pre-NAC core needle biopsy were associated with higher pCR rate and better prognosis in HER2-positive breast cancers.
A 20% threshold for sTILs may be feasible to predict pCR to NAC and prognosis in HER2-positive breast cancers.